The short answer
Get prescriber advice before using yohimbe with prazosin. Yohimbine can raise blood pressure and product content is unpredictable, but a specific prazosin interaction or protective spacing interval has not been established.
What this answer covers
Oral prazosin with Pausinystalia johimbe bark products. Yohimbine tablets provide constituent evidence and are not dose-equivalent to an unspecified botanical.
- Supplement or preparation
- Pausinystalia johimbe
- Medication ingredient
- prazosin
The blood-pressure evidence is about yohimbine
A study in 25 unmedicated hypertensive adults found a rise in average BP after a single oral yohimbine dose. It did not test prazosin or whole yohimbe bark. A pressor effect from the isolated alkaloid cannot define what an unknown bark product will do.
Botanical strength is unpredictable
An analysis of 49 marketed products found yohimbine amounts ranging from undetected to 12.1 mg per serving and frequent inaccurate labels. Some products appeared highly processed or potentially synthetic. The brand name or bark weight alone cannot establish the active exposure.
Use a product review, not a guessed gap
NCCIH advises discussing medicine use before taking yohimbe because of BP and other serious adverse-effect concerns. For someone taking prazosin for hypertension, a BP-raising product can be a poor fit. These sources do not establish that separating doses prevents a problem.
Share symptoms and all ingredients
Tell your clinician about the exact product, other stimulants and changes in pressure or pulse. Prazosin can itself cause faintness, so do not adjust it to counter a supplement without advice. Seek prompt assessment for marked palpitations, severe symptoms or fainting.
Evidence and practical considerations
Side effects & toxicity
Yohimbine pressor effects and variable yohimbe composition justify a precautionary review, not a proven prazosin-specific avoidance or timing rule.
- Exact scope
- Oral prazosin with Pausinystalia johimbe bark products. Yohimbine tablets provide constituent evidence and are not dose-equivalent to an unspecified botanical. with Current RxNorm confirms prazosin RxCUI 8629 IN. Hydrochloride polyhydrate capsules provide the equivalent of prazosin 1, 2 or 5 mg. Oral formulation only.
- Medication form and route
- Oral
What remains uncertain
- Constituent-only human trial and historical product analysis; no exact prazosin-bark interaction or validated interval.
Factors that may matter: Exact preparation and dose; Blood pressure and symptoms; Treatment initiation or dose change; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed prazosin hydrochloride capsules.
Postural hypotension, fainting and drowsiness can occur, particularly with initiation, dose escalation or additional BP-lowering medication.
How this applies: Exact ingredient through the stated labeled salt and oral formulation. Current RxNorm confirms prazosin RxCUI 8629 IN. Hydrochloride polyhydrate capsules provide the equivalent of prazosin 1, 2 or 5 mg. Oral formulation only.
No botanical interaction established merely by these drug-alone warnings.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 25 unmedicated hypertensive adults.
Mean BP rose about 5 mm Hg at one hour with increased norepinephrine.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured prazosin combination unless explicitly stated.
Abstract-only; constituent evidence, not measured prazosin co-use, botanical dose equivalence or validated spacing.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 49 US brands labeled yohimbe or yohimbine.
Yohimbine ranged from undetected to 12.1 mg; many products lacked other expected bark alkaloids and labeling was often inaccurate.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured prazosin combination unless explicitly stated.
Abstract-only; historical products, not the user’s product, and no clinical interaction outcomes.
Source 4: Federal health guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Yohimbe supplement users.
BP problems and other serious adverse effects reported; recommends discussing any medicine use before yohimbe.
How this applies: Constituent and disease precaution only.
Does not specifically establish a prazosin interaction or effective dose gap.
Source 5: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
prazosin is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: 421d3d44fcbbe4e1
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.